Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle.

Muscular dystrophies comprise a genetically heterogeneous group of degenerative muscle disorders characterized by progressive muscle wasting and weakness. Two forms of limb-girdle muscular dystrophy, 2A and 2B, are caused by mutations in calpain 3 (CAPN3) and dysferlin (DYSF), respectively. While CAPN3 may be involved in sarcomere remodeling, DYSF is proposed to play a role in membrane repair. The coexistence of CAPN3 and AHNAK, a protein involved in subsarcolemmal cytoarchitecture and membrane repair, in the dysferlin protein complex and the presence of proteolytic cleavage fragments of AHNAK in skeletal muscle led us to investigate whether AHNAK can act as substrate for CAPN3. We here demonstrate that AHNAK is cleaved by CAPN3 and show that AHNAK is lost in cells expressing active CAPN3. Conversely, AHNAK accumulates when calpain 3 is defective in skeletal muscle of calpainopathy patients. Moreover, we demonstrate that AHNAK fragments cleaved by CAPN3 have lost their affinity for dysferlin. Thus, our findings suggest interconnectivity between both diseases by revealing a novel physiological role for CAPN3 in regulating the dysferlin protein complex.

[1]  J. Meldolesi,et al.  Regulated exocytosis: a novel, widely expressed system , 2002, Nature Cell Biology.

[2]  R. Flavell,et al.  The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  F. Cohen,et al.  A human gene (AHNAK) encoding an unusually large protein with a 1.2-microns polyionic rod structure. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[4]  E. Kudryashova,et al.  Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiquitin-proteasome pathway. , 2007, Human molecular genetics.

[5]  J. T. Dunnen,et al.  AHNAK a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  V. Regitz-Zagrosek,et al.  The FASEB Journal • Research Communication Ahnak is critical for cardiac Ca(v)1.2 calcium channel function and its �-adrenergic regulation , 2022 .

[7]  Chien-Chang Chen,et al.  Defective membrane repair in dysferlin-deficient muscular dystrophy , 2003, Nature.

[8]  K. Bushby,et al.  Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display , 2005, European Journal of Human Genetics.

[9]  Volker Gerke,et al.  Identification of an AHNAK Binding Motif Specific for the Annexin2/S100A10 Tetramer* , 2006, Journal of Biological Chemistry.

[10]  C. Delphin,et al.  Expression of the Giant Protein AHNAK (Desmoyokin) in Muscle and Lining Epithelial Cells , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[11]  K. Miyake,et al.  Calpain Is Required for the Rapid, Calcium-dependent Repair of Wounded Plasma Membrane* , 2007, Journal of Biological Chemistry.

[12]  N. Bourg,et al.  Calpain 3 Is Activated through Autolysis within the Active Site and Lyses Sarcomeric and Sarcolemmal Components , 2003, Molecular and Cellular Biology.

[13]  J. Beckmann,et al.  Calpain 3 cleaves filamin C and regulates its ability to interact with gamma- and delta-sarcoglycans. , 2003, Muscle & nerve.

[14]  J. Beckmann,et al.  A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B , 1998, Nature Genetics.

[15]  N. Shimizu,et al.  Localization of the human AHNAK/desmoyokin gene (AHNAK) to chromosome band 11q12 by somatic cell hybrid analysis and fluorescence in situ hybridization. , 1995, Cytogenetics and cell genetics.

[16]  E. McNally,et al.  The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. , 2004, Circulation research.

[17]  C. Delphin,et al.  Specific AHNAK expression in brain endothelial cells with barrier properties , 2005, Journal of cellular physiology.

[18]  R. Mellgren,et al.  Fetuin A Stabilizes m-Calpain and Facilitates Plasma Membrane Repair* , 2007, Journal of Biological Chemistry.

[19]  M. Baiget,et al.  Distal anterior compartment myopathy: A dysferlin mutation causing a new muscular dystrophy phenotype , 2001, Annals of neurology.

[20]  R. Campbell,et al.  Insertion Sequence 1 of Muscle-specific Calpain, p94, Acts as an Internal Propeptide* , 2004, Journal of Biological Chemistry.

[21]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[22]  J. Beckmann,et al.  A biochemical, genetic, and clinical survey of autosomal recessive limb girdle muscular dystrophies in Turkey , 1997, Annals of neurology.

[23]  R. Kraft,et al.  Signaling from β‐adrenoceptor to L‐type calcium channel: identification of a novel cardiac protein kinase A target possessing similarities to AHNAK , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  Isabelle Richard,et al.  Calpain 3: a key regulator of the sarcomere? , 2006, The FEBS journal.

[25]  J. Behlke,et al.  The carboxyl‐terminal region of ahnak provides a link between cardiac L‐type Ca2+ channels and the actinbased cytoskeleton , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  Isabelle Richard,et al.  Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A , 1995, Cell.

[27]  C. Angelini,et al.  Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes , 2005, Journal of Medical Genetics.

[28]  J. Beckmann,et al.  Loss of Calpain 3 Proteolytic Activity Leads to Muscular Dystrophy and to Apoptosis-Associated Iκbα/Nuclear Factor κb Pathway Perturbation in Mice , 2000, The Journal of cell biology.

[29]  J. Schaper,et al.  The carboxyl‐terminal ahnak domain induces actin bundling and stabilizes muscle contraction , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  D. Davis,et al.  Myoferlin, a candidate gene and potential modifier of muscular dystrophy. , 2000, Human molecular genetics.

[31]  Pieter J. de Jong,et al.  Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy , 1998, Nature Genetics.